67
Views
9
CrossRef citations to date
0
Altmetric
Review

Type 1 diabetes: entering the proteomic era

, &
Pages 223-236 | Published online: 09 Jan 2014

References

  • Wilkins M, Gooley A, Williams K et al. Towards the protein genome: rapid identification of 2D spots by amino acid analysis. Siena Meeting on 2D Electrophoresis. Siena, Italy, 35–36 (1994).
  • Overbergh L, Gysemans C, Mathieu C. Quantification of chemokines by real-time reverse transcriptase PCR: applications in Type 1 diabetes. Expert Rev. Mol. Diagn.6, 51–64 (2006).
  • Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis18, 533–537 (1997).
  • Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol.19, 1720–1730 (1999).
  • Baltimore D. Our genome unveiled. Nature409, 814–816 (2001).
  • Kaltschmidt E, Wittmann HG. Ribosomal proteins. VII. Two-dimensional polyacrylamide gel electrophoresis for fingerprinting of ribosomal proteins. Anal. Biochem.36, 401–412 (1970).
  • Smolka M, Zhou H, Aebersold R. Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol. Cell. Proteomics1, 19–29 (2002).
  • Stutz H. Advances in the analysis of proteins and peptides by capillary electrophoresis with matrix-assisted laser desorption/ionization and electrospray-mass spectrometry detection. Electrophoresis26, 1254–1290 (2005).
  • Raymond S, Wang YJ. Preparation and properties of acrylamide gel for use in electrophoresis. Anal. Biochem.1, 391–396 (1960).
  • O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem.250, 4007–4021 (1975).
  • Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik26, 231–243 (1975).
  • Bjellqvist B, Ek K, Righetti PG et al. Isoelectric focusing in immobilized pH gradients: principle, methodology and some applications. J. Biochem. Biophys. Methods6, 317–339 (1982).
  • Klose J. Genotypes and phenotypes. Electrophoresis20, 643–652 (1999).
  • Zahedi RP, Meisinger C, Sickmann A. Two-dimensional benzyldimethyl-n-hexadecylammonium chloride/SDS-PAGE for membrane proteomics. Proteomics5, 3581–3588 (2005).
  • Stegemann J, Ventzki R, Schrodel A, de Marco A. Comparative analysis of protein aggregates by blue native electrophoresis and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis in a three-dimensional geometry gel. Proteomics5, 2002–2009 (2005).
  • McDonough J, Marban E. Optimization of IPG strip equilibration for the basic membrane protein mABC1. Proteomics5, 2892–2895 (2005).
  • Gorg A, Boguth G, Kopf A, Reil G, Parlar H, Weiss W. Sample prefractionation with Sephadex isoelectric focusing prior to narrow pH range two-dimensional gels. Proteomics2, 1652–1657 (2002).
  • Van den Bergh G, Clerens S, Vandesande F, Arckens L. Reversed-phase high-performance liquid chromatography prefractionation prior to two-dimensional difference gel electrophoresis and mass spectrometry identifies new differentially expressed proteins between striate cortex of kitten and adult cat. Electrophoresis24, 1471–1481 (2003).
  • Hanson BJ, Schulenberg B, Patton WF, Capaldi RA. A novel subfractionation approach for mitochondrial proteins: a three-dimensional mitochondrial proteome map. Electrophoresis22, 950–959 (2001).
  • Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics4, 3665–3685 (2004).
  • Westermeier R, Marouga R. Protein detection methods in proteomics research. Biosci. Rep.25, 19–32 (2005).
  • Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis18, 2071–2077 (1997).
  • Tonge R, Shaw J, Middleton B et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics1, 377–396 (2001).
  • Van Den Bergh G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr. Opin. Biotechnol.15, 38–43 (2004).
  • Shaw J, Rowlinson R, Nickson J et al. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics3, 1181–1195 (2003).
  • Coghlan DR, Mackintosh JA, Karuso P. Mechanism of reversible fluorescent staining of protein with epicocconone. Org. Lett.7, 2401–2404 (2005).
  • Berggren KN, Schulenberg B, Lopez MF et al. An improved formulation of SYPRO Ruby protein gel stain: comparison with the original formulation and with a ruthenium II tris (bathophenanthroline disulfonate) formulation. Proteomics2, 486–498 (2002).
  • Steinberg TH, Agnew BJ, Gee KR et al. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics3, 1128–1144 (2003).
  • Schulenberg B, Patton WF. Combining microscale solution-phase isoelectric focusing with multiplexed proteomics dye staining to analyze protein post-translational modifications. Electrophoresis25, 2539–2544 (2004).
  • Wu J, Lenchik NJ, Pabst MJ, Solomon SS, Shull J, Gerling IC. Functional characterization of two-dimensional gel-separated proteins using sequential staining. Electrophoresis26, 225–237 (2005).
  • Nijtmans LG, Henderson NS, Holt IJ. Blue native electrophoresis to study mitochondrial and other protein complexes. Methods26, 327–334 (2002).
  • Schagger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal. Biochem.199, 223–231 (1991).
  • Fandino AS, Rais I, Vollmer M, Elgass H, Schagger H, Karas M. LC-nanospray-MS/MS analysis of hydrophobic proteins from membrane protein complexes isolated by blue-native electrophoresis. J. Mass Spectrom.40, 1223–1231 (2005).
  • Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem.60, 2299–2301 (1988).
  • Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science246, 64–71 (1989).
  • Ishihama Y. Proteomic LC-MS systems using nanoscale liquid chromatography with tandem mass spectrometry. J. Chromatogr. A1067, 73–83 (2005).
  • Nagele E, Vollmer M, Horth P. Two-dimensional nano-liquid chromatography-mass spectrometry system for applications in proteomics. J. Chromatogr. A1009, 197–205 (2003).
  • Husson SJ, Clynen E, Baggerman G, De Loof A, Schoofs L. Discovering neuropeptides in Caenorhabditis elegans by two dimensional liquid chromatography and mass spectrometry. Biochem. Biophys. Res. Commun.335, 76–86 (2005).
  • Baggerman G, Vierstraete E, De Loof A, Schoofs L. Gel-based versus gel-free proteomics: a review. Comb. Chem. High Throughput Screen.8, 669–677 (2005).
  • Washburn MP, Wolters D, Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nature Biotechnol.19, 242–247 (2001).
  • Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics3, 1154–1169 (2004).
  • Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1, 376–386 (2002).
  • Kirkpatrick DS, Gerber SA, Gygi SP. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods35, 265–273 (2005).
  • Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol.17, 994–999 (1999).
  • Zhou H, Ranish JA, Watts JD, Aebersold R. Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nature Biotechnol.20, 512–515 (2002).
  • Munchbach M, Quadroni M, Miotto G, James P. Quantitation and facilitated de novo sequencing of proteins by isotopic N-terminal labeling of peptides with a fragmentation-directing moiety. Anal. Chem.72, 4047–4057 (2000).
  • Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc. Natl Acad. Sci. USA96, 14694–14699 (1999).
  • Greenbaum D, Medzihradszky KF, Burlingame A, Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol.7, 569–581 (2000).
  • Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nature Biotechnol.19, 379–382 (2001).
  • Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nature Biotechnol.21, 660–666 (2003).
  • Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. Accurate quantitation of protein expression and site-specific phosphorylation. Proc. Natl Acad. Sci. USA96, 6591–6596 (1999).
  • Snijders AP, de Vos MG, de Koning B, Wright PC. A fast method for quantitative proteomics based on a combination between two-dimensional electrophoresis and 15N-metabolic labelling. Electrophoresis26, 3191–3199 (2005).
  • Ong SE, Kratchmarova I, Mann M. Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J. Proteome Res.2, 173–181 (2003).
  • Ong SE, Mittler G, Mann M. Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nature Methods1, 119–126 (2004).
  • Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem.73, 2836–2842 (2001).
  • Stewart II, Thomson T, Figeys D. 18O labeling: a tool for proteomics. Rapid Commun. Mass Spectrom.15, 2456–2465 (2001).
  • Barr JR, Maggio VL, Patterson DG Jr et al. Isotope dilution – mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin. Chem.42, 1676–1682 (1996).
  • Ciechanover A, Heller H, Elias S, Haas AL, Hershko A. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc. Natl Acad. Sci. USA77, 1365–1368 (1980).
  • Tyers M, Jorgensen P. Proteolysis and the cell cycle: with this RING I do thee destroy. Curr. Opin. Genet. Dev.10, 54–64 (2000).
  • Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta1473, 4–8 (1999).
  • Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nature Biotechnol.21, 255–261 (2003).
  • Reinders J, Lewandrowski U, Moebius J, Wagner Y, Sickmann A. Challenges in mass spectrometry-based proteomics. Proteomics4, 3686–3703 (2004).
  • Aebersold R, Goodlett DR. Mass spectrometry in proteomics. Chem. Rev.101, 269–295 (2001).
  • Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom. Rev.23, 34–44 (2004).
  • Hess JL, Blazer L, Romer T, Faber L, Buller RM, Boyle MD. Immunoproteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.815, 65–75 (2005).
  • Vitzthum F, Behrens F, Anderson NL, Shaw JH. Proteomics: from basic research to diagnostic application. A review of requirements and needs. J. Proteome Res.4, 1086–1097 (2005).
  • Winer S, Tsui H, Lau A et al. Autoimmune islet destruction in spontaneous Type 1 diabetes is not β-cell exclusive. Nature Med.9, 198–205 (2003).
  • Wright GL Jr. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev. Mol. Diagn.2, 549–563 (2002).
  • Combaret V, Bergeron C, Brejon S et al. Protein chip array profiling analysis of sera from neuroblastoma patients. Cancer Lett.228, 91–96 (2005).
  • Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572–577 (2002).
  • de Seny D, Fillet M, Meuwis MA et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum.52, 3801–3812 (2005).
  • Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics20, 777–785 (2004).
  • Mathis D, Vence L, Benoist C. β-cell death during progression to diabetes. Nature414, 792–798 (2001).
  • Stoffels K, Overbergh L, Giulietti A et al. NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J. Autoimmun.23, 9–15 (2004).
  • Kutlu B, Cardozo AK, Darville MI et al. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes52, 2701–2719 (2003).
  • Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia46, 255–266 (2003).
  • Rieneck K, Bovin LF, Josefsen K, Buschard K, Svenson M, Bendtzen K. Massive parallel gene expression profiling of RINm5F pancreatic islet β-cells stimulated with interleukin-1β. APMIS108, 855–872 (2000).
  • Nielsen K, Kruhoffer M, Orntoft T et al. Gene expression profiles during β cell maturation and after IL-1β exposure reveal important roles of Pdx-1 and Nkx6.1 for IL-1β sensitivity. Diabetologia47, 2185–2199 (2004).
  • Cardozo AK, Heimberg H, Heremans Y et al. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem.276, 48879–48886 (2001).
  • Heimberg H, Heremans Y, Jobin C et al. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes50, 2219–2224 (2001).
  • Nielsen K, Sparre T, Larsen MR et al. Protein expression changes in a cell system of β-cell maturation reflect an acquired sensitivity to IL-1β. Diabetologia47, 62–74 (2004).
  • John NE, Andersen HU, Fey SJ et al. Cytokine- or chemically derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans. Diabetes49, 1819–1829 (2000).
  • Larsen PM, Fey SJ, Larsen MR et al. Proteome analysis of interleukin-1β-induced changes in protein expression in rat islets of Langerhans. Diabetes50, 1056–1063 (2001).
  • Hu X, Friedman D, Hill S et al. Proteomic exploration of pancreatic islets in mice null for the α2A adrenergic receptor. J. Mol. Endocrinol.35, 73–88 (2005).
  • Sparre T, Christensen UB, Gotfredsen CF et al. Changes in expression of IL-1β influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats. Diabetologia47, 892–908 (2004).
  • Christensen UB, Larsen PM, Fey SJ et al. Islet protein expression changes during diabetes development in islet syngrafts in BB-DP rats and during rejection of BB-DP islet allografts. Autoimmunity32, 1–15 (2000).
  • Arif S, Tree TI, Astill TP et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest113, 451–463 (2004).
  • Mannering SI, Harrison LC, Williamson NA et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J. Exp. Med.202(9), 1191–1197 (2005).
  • Wittke S, Mischak H, Walden M, Kolch W, Radler T, Wiedemann K. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis26, 1476–1487 (2005).
  • Baekkeskov S, Warnock G, Christie M, Rajotte RV, Larsen PM, Fey S. Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes38, 1133–1141 (1989).
  • Andersen HU, Larsen PM, Fey SJ, Karlsen AE, Mandrup-Poulsen T, Nerup J. Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 β-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes44, 400–407 (1995).
  • Andersen HU, Fey SJ, Larsen PM et al. Interleukin-1β induced changes in the protein expression of rat islets: a computerized database. Electrophoresis18, 2091–2103 (1997).
  • Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J. Clin. Invest86, 856–863 (1990).
  • Sparre T, Christensen UB, Mose LP et al. IL-1β induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia45, 1550–1561 (2002).
  • Sparre T, Reusens B, Cherif H et al. Intrauterine programming of fetal islet gene expression in rats – effects of maternal protein restriction during gestation revealed by proteome analysis. Diabetologia46, 1497–1511 (2003).
  • Sparre T, Bergholdt R, Nerup J, Pociot F. Application of genomics and proteomics in Type 1 diabetes pathogenesis research. Expert Rev. Mol. Diagn.3, 743–757 (2003).
  • Sparre T, Larsen MR, Heding PE, Karlsen AE, Jensen ON, Pociot F. Unraveling the pathogenesis of Type 1 diabetes with proteomics: present and future directions. Mol. Cell. Proteomics4, 441–457 (2005).
  • Sanchez JC, Chiappe D, Converset V et al. The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity. Proteomics1, 136–163 (2001).
  • Sanchez JC, Converset V, Nolan A et al. Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice. Mol. Cell. Proteomics1, 509–516 (2002).
  • Nicolls MR, D’Antonio JM, Hutton JC, Gill RG, Czwornog JL, Duncan MW. Proteomics as a tool for discovery: proteins implicated in Alzheimer’s disease are highly expressed in normal pancreatic islets. J. Proteome Res.2, 199–205 (2003).
  • Ahmed M, Bergsten P. Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel electrophoresis and mass spectrometry. Diabetologia48, 477–485 (2005).
  • Thongboonkerd V, Barati MT, McLeish KR et al. Alterations in the renal elastin-elastase system in Type 1 diabetic nephropathy identified by proteomic analysis. J. Am. Soc. Nephrol.15, 650–662 (2004).
  • Hu L, Evers S, Lu ZH, Shen Y, Chen J. Two-dimensional protein database of human pancreas. Electrophoresis25, 512–518 (2004).
  • Ahmed M, Forsberg J, Bergsten P. Protein profiling of human pancreatic islets by two-dimensional gel electrophoresis and mass spectrometry. J. Proteome Res.4, 931–940 (2005).
  • Meier M, Kaiser T, Herrmann A et al. Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J. Diabetes Complications19, 223–232 (2005).
  • Rossing K, Mischak H, Parving HH et al. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int.68, 193–205 (2005).
  • Westman-Brinkmalm A, Karlsson G, Brive LM et al. Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom.19, 3651–3658 (2005).
  • Poland J, Cahill MA, Sinha P. Isoelectric focusing in long immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis24, 1271–1275 (2003).
  • Poznanovic S, Schwall G, Zengerling H, Cahill MA. Isoelectric focusing in serial immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis26, 3185–3190 (2005).
  • Poznanovic S, Wozny W, Schwall GP et al. Differential radioactive proteomic analysis of microdissected renal cell carcinoma tissue by 54 cm isoelectric focusing in serial immobilized pH gradient gels. J. Proteome Res.4, 2117–2125 (2005).
  • Soloviev M, Finch P. Peptidomics, current status. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.815, 11–24 (2005).
  • Baggerman G, Verleyen P, Clynen E, Huybrechts J, De Loof A, Schoofs L. Peptidomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.803, 3–16 (2004).
  • Ivanov VT, Yatskin ON. Peptidomics: a logical sequel to proteomics. Expert Rev. Proteomics2, 463–473 (2005).
  • Schoofs L, Baggerman G. Peptidomics in Drosophila melanogaster. Brief Funct. Genomic. Proteomic.2, 114–120 (2003).
  • Hummon AB, Amare A, Sweedler JV. Discovering new invertebrate neuropeptides using mass spectrometry. Mass Spectrom. Rev.25, 77–98 (2006).
  • Rahman SM, Shyr Y, Yildiz PB et al. Proteomic patterns of preinvasive bronchial lesions. Am. J. Respir. Crit. Care Med.172, 1556–1562 (2005).
  • Zheng Y, Xu Y, Ye B et al. Prostate carcinoma tissue proteomics for biomarker discovery. Cancer98, 2576–2582 (2003).
  • Reyzer ML, Hsieh Y, Ng K, Korfmacher WA, Caprioli RM. Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom.38, 1081–1092 (2003).
  • Chaurand P, Sanders ME, Jensen RA, Caprioli RM. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am. J. Pathol.165, 1057–1068 (2004).
  • Caldwell RL, Caprioli RM. Tissue profiling by mass spectrometry: a review of methodology and applications. Mol. Cell. Proteomics4, 394–401 (2005).

Websites

  • SWISS 2D-PAGE. Map Selection: ISLETS_MOUSE www.expasy.org/cgi-bin/map2/def?ISLETS_ MOUSE
  • MEDLINE www.ncbi.nlm.nih.gov/entrez/query.fcgi

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.